دوره 5، شماره 4 - ( volume 5, number 4 1392 )                   جلد 5 شماره 4 صفحات 171-175 | برگشت به فهرست نسخه ها


XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghadiri-Anari A, Jafari-Mehdiabad A H, Afkhami-Ardekani M, Rezapour M, Chavoshzadeh-Tafti F. Prevalence of Aspirin Use among Type 2 Diabetic Patients in Iran. IJDO. 2013; 5 (4) :171-175
URL: http://ijdo.ssu.ac.ir/article-1-167-fa.html
Prevalence of Aspirin Use among Type 2 Diabetic Patients in Iran. دیابت و چاقی. 1392; 5 (4) :171-175

URL: http://ijdo.ssu.ac.ir/article-1-167-fa.html


چکیده:   (1196 مشاهده)
Abstract Objective: Patients with type 2 diabetes mellitus (DM) have a markedly increased risk of cardiovascular morbidity and mortality. There are some recommendations for prescription of aspirin in these patients. Our purpose was to determine aspirin usage rate in diabetic patients and to compare it in different ages and based upon cardiovascular disease (CVD) risk factors. Materials and Methods: In this study we collected data from 1256 self-reported diabetes mellitus patients referred to Yazd Diabetes Research Center during 2010-2011. This data included age, sex, history of diabetes mellitus, drug history, antiplatelet therapy duration, smoking, hypertension, dyslipidemia, family history of premature CVD and albuminuria. Results: 48.5% of patients were male (609 patients) and 51.5% were female (647 patients). From female patients ≤60 years old, 52.7% used antiplatelet drug however, this percent for patients over 60 years was 58.9% and for male patients ≤50 and >50 was 47.7% and 81%, respectively. From antiplatelet drug users, 43.1% of males aged ≤50 and 29.2% of females aged ≤60 years old had no or one risk factor that is unnecessary to take it. Conclusion: Physician must encourage diabetic patients to use aspirin when the potential benefit of a reduction in cardiovascular disease outweighs the potential harms. So, clinical judgment is required for prescription of aspirin in men aged ≤ 50 years and women aged ≤ 60 years without multiple risk factors.
متن کامل [PDF 81 kb]   (412 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: تخصصي
دریافت: ۱۳۹۳/۷/۱۲ | پذیرش: ۱۳۹۳/۷/۱۲ | انتشار: ۱۳۹۳/۷/۱۲

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
کد امنیتی را در کادر بنویسید

کلیه حقوق این وب سایت متعلق به مجله ایرانی دیابت و چاقی می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2015 All Rights Reserved | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb